𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration

✍ Scribed by Matonti, Frédéric; Courjaret, Jean Christophe; Hoffart, Louis; Amouyal, Franck; Denis, Danièle

Book ID
123003821
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
65 KB
Volume
120
Category
Article
ISSN
0161-6420

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab for Neovascular Age-Related
Ranibizumab for Neovascular Age-Related Macular Degeneration
✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha